Expert Interview
Discussing the recent approval of Avmapki Fakzynja Co-pack in LGSOC ( low-grade serous ovarian cancer) from Verastem
Ticker(s): VSTMInstitution: Kaiser Permanente
- Gynecologist oncologist at Kaiser Permanente Riverside Medical Center (CA).
- Treats 10 LGSOC patients annually
- Familiar with investigational agents in gynecologic oncology
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
